About this Journal Submit a Manuscript Table of Contents
ISRN Oncology
Volume 2013 (2013), Article ID 536529, 14 pages
http://dx.doi.org/10.1155/2013/536529
Review Article

Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated Proteins

Department of Pharmacology, Wayne State University, 540 East Canfield Avenue, Detroit, MI 48201, USA

Received 15 September 2013; Accepted 4 October 2013

Academic Editors: M. Folini, M. Santarosa, and R. V. Sionov

Copyright © 2013 Raymond R. Mattingly. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Raymond R. Mattingly, “Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated Proteins,” ISRN Oncology, vol. 2013, Article ID 536529, 14 pages, 2013. doi:10.1155/2013/536529